Results 131 to 140 of about 68,702 (192)

Distinct mechanisms of recognition of phosphorylated RNAPII C-terminal domain by BRCT repeats of the BRCA1-BARD1 complex. [PDF]

J Biol Chem
Klapstova V, Sedova K, Houser J, Sebesta M.   +3 more
europepmc   +1 more source

Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer. [PDF]

NPJ Breast Cancer
Pasanisi J, Lamy C, Lecompte L, Vacher S, Schwartz M, Hamza A, Caputo SM, Ibadioune S, Courtois L, Berger F, Cockenpot V, Baulande S, Pierga JY, Callens C, Melaabi S, Colas C, Pasmant E, Kamal M, Dupain C, Servant N, Le Tourneau C, Bièche I.   +21 more
europepmc   +1 more source

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors. [PDF]

J Cancer Res Clin Oncol
Jörg I, Chronas D.
europepmc   +1 more source

Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. [PDF]

Curr Oncol
Skoczylas S, Płoszaj T, Dróżdż I, Moczulska H, Serafin M, Piekarska K, Wojtyczka O, Żeżawska K, Zmysłowska A.   +8 more
europepmc   +1 more source

Functional analysis of BRCA1 and BRCA2 splicing variants using a minigene assay. [PDF]

Hum Genomics
Yim H, Youn S, Chae SW, Kim Y, Jang J, Cho SI, Lee JS, Seong MW.   +7 more
europepmc   +1 more source

Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype-Phenotype Correlations. [PDF]

Mol Genet Genomic Med
Bujassoum Al-Bader S, Al-Mulla H, Al-Habish H, Kusasi S, Abduo N, Bakheet N, Ghazouani H, Sidenna M, Abbaszadeh F, Alsulaiman R.   +9 more
europepmc   +1 more source

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan. [PDF]

Sci Rep
Samigatova A, Altaeva N, Suleimenov Y, Sibiryakov P, Zhabagin K, Zhakypbekkyzy Z, Seksenbayev B, Yoshihiro N, Tsigengagel O.   +8 more
europepmc   +1 more source

High-Grade Serous Ovarian Carcinoma in the Genomics Era: Current Applications, Challenges and Future Directions. [PDF]

Int J Mol Sci
Lewis ME, Caricato C, Roberts HL, Ganesan S, Seksaf NA, Maniati E, Sideris M.   +6 more
europepmc   +1 more source

Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic Implications. [PDF]

Cancer Med
Lin DI, Lawrence E, Danziger N, Ye H, Decker B, Gjoerup O, Graf RP, Ross JS, Huang RSP, Elvin JA, Mata DA, McKay RR.   +11 more
europepmc   +1 more source

Machine learning prediction of germline <i>BRCA1/2</i> pathogenic variants in patients with ovarian cancer. [PDF]

BMJ Health Care Inform
Innella G, Erini G, De Leo A, Godino L, Caramanna L, Ferrari S, Miccoli S, Perrone AM, Zamagni C, De Iaco P, Turchetti D, Rucci P.   +11 more
europepmc   +1 more source